| Serial Number | 79331573 |
| Word Mark | ASD - HIPROS |
| Filing Date | Friday, May 7, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 27, 2022 |
| Registration Number | 6932819 |
| Registration Date | Tuesday, December 27, 2022 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 11, 2022 |
| Goods and Services | Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems of humans or animals; compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; medical diagnostic compositions, namely medical diagnostic reagents; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals |
| Goods and Services | Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research in the field of optimizing of manufacturing processes for the pharmaceutical industry |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 21, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 21, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Hovione Scientia Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | IE |
| Party Name | Hovione Scientia Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | IE |
| Party Name | Hovione Scientia Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | IE |
| Event Date | Event Description |
| Thursday, January 20, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, January 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 21, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, January 25, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 28, 2022 | NON-FINAL ACTION WRITTEN |
| Saturday, January 29, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, February 28, 2022 | REFUSAL PROCESSED BY MPU |
| Monday, February 28, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, March 22, 2022 | REFUSAL PROCESSED BY IB |
| Tuesday, August 16, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 16, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 16, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 8, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 21, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 21, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 21, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, October 10, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, October 11, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 11, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 27, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 27, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Sunday, February 12, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, March 27, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, April 13, 2023 | FINAL DISPOSITION PROCESSED |
| Friday, April 14, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, May 10, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, June 26, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |